Efficacy of Topical Azithromycin versus Systemic Doxycycline in Treatment of Meibomian Gland Dysfunction

Table 2

Pain and discomfort, lid margin telangiectasia, conjunctivitis, frothy discharge, meniscus floaters and break-up time test in 1^ry visit between studied groups.

		Topical azithromycin (n = 28)	Systemic doxycycline (n = 28)	value
Pain and discomfort	Mild	6 (21.43%)	5 (17.86%)	0.248
	Moderate	12 (42.86%)	7 (25.00%)
	Severe	10 (35.71%)	16 (57.14%)
Lid margin telangiectasia	0 & 1	1 (3.57%)	2 (7.14%)	0.661
	2	7 (25.00%)	9 (32.14%)
	3	20 (71.43%)	17 (60.71%)
Conjunctivitis	+ve	16 (57.14%)	19 (57.86%)	0.407
	−ve	12 (42.86%)	9 (32.14%)
Frothy discharge	+ve	25 (89.28%)	21 (75%)	0.295
	−ve	3 (10.71%)	7 (25%)
Meniscus floaters	+ve	21 (75.00%)	22 (78.57%)	0.751
	−ve	7 (25.00%)	6 (21.43%)
Break-up time test (seconds)		6.25 ± 2.07	6.54 ± 1.88	0.590
		2–9	3–9

Data are presented as mean ± SD.